Rheinfelden, Switzerland

Ulf Neumann

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.6

ph-index = 1


Company Filing History:


Years Active: 2002-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ulf Neumann in Pharmaceutical Patents

Introduction

Ulf Neumann, an accomplished inventor based in Rheinfelden, Switzerland, has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a portfolio that includes three patents, Neumann's work focuses on treatments for various medical conditions, showcasing his dedication to advancing healthcare.

Latest Patents

Neumann's latest patents highlight his expertise in developing novel pharmaceutical compounds. One of his notable inventions is the "Oxazine derivative for use in the treatment or prevention of cerebral amyloid angiopathy." This invention relates to an oxazine derivative BACE-1 inhibitor, along with pharmaceutical compositions designed to treat patients, particularly those carrying one or two copies of the ApoE4 allele.

Another significant patent addresses "Hydroxamic acid derivatives." These novel compounds have been identified as useful pharmaceuticals for suppressing TNF release and treating autoimmune and inflammatory diseases, such as multiple sclerosis and rheumatoid arthritis. The patent provides methods for making these compounds, as well as novel intermediates and pharmaceutical compositions that include them.

Career Highlights

Ulf Neumann is currently employed by Novartis AG, a global healthcare company renowned for its focus on research and innovation. His work at Novartis has positioned him at the forefront of pharmaceutical development, allowing him to contribute to groundbreaking advancements in treatment options for various diseases.

Collaborations

Throughout his career, Neumann has collaborated with several talented colleagues, including Cristina Lopez-Lopez and Derya Shimshek. These collaborations enhance the quality of his research and contribute to the successful development of his innovative patents.

Conclusion

Ulf Neumann’s contributions to the field of pharmaceuticals through his patents exemplify the importance of innovation in medical treatments. With a focus on addressing critical health concerns, his work not only showcases his skills as an inventor but also has the potential to significantly impact patients' lives around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…